Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2025-07-25 to 2025-08-04
Current total value of award: $373.44
Description: 8511530837!CLONAZEPAM TABLETS